UnitedHealth Group is bailing out of Latin America, torching $8 billion in losses like a bad vacation gone way over budget.

In 2018, UnitedHealth acquired Chilean healthcare company Banmedica in a deal worth $2.8 billion. The deal, however, hasn't ...

Corporate bonds issued by United Healthcare to repay all or part of about $8.2 billion in existing debt earned an 'A+' investment-grade rating from S&P Global Ratings on Tuesday. The company is ...

Humana's growth trajectory could rebound from current weakness, with management calling for pretax profits to more than double from 2025 to 2028 and grow in the low double digits in the long run at ...

UnitedHealth Group is feeling the chill as analysts at Baird R W dropped its rating from “strong-buy” to “hold.” Other firms ...

After digesting Cardinal Health's 2025 investor day, we inched up our 2026 revenue and EPS assumptions and lifted our stage II growth rates by 50 basis points to reflect a stronger distribution market ...

Moody's and S&P Global noted their downgrades were unusual for the insurance giant and expressed optimism that the company will overcome multiple operational difficulties, Modern Healthcare reported.

Most of UnitedHealth Group's issues should be temporary. The price is right to buy UnitedHealth Group stock after its steep ...

UnitedHealth Group (UNH) is back in the spotlight with a new dividend increase, bumping its quarterly payout from $2.10 to $2.21 per share. UnitedHealth’s annual dividend now totals $8.84 per share, ...

The market’s recent run higher took a breather as major indexes ended the session near previous closing levels.

The rating agency maintained UnitedHealth’s (NYSE: UNH) senior unsecured debt rating at A2 and its P-1 short-term commercial paper rating. Moody’s also affirmed ratings for United HealthCare Services, ...

UnitedHealth is reviewing four bids for its Latin American unit Banmedica, aiming to finalize a sale amid financial setbacks ...